{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:17:07Z","timestamp":1792621027419,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1316-8","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T13:02:38Z","timestamp":1563368558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods"],"prefix":"10.1186","volume":"10","author":[{"given":"Fatma Visal","family":"Okur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130nci","family":"Cevher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7etin","family":"Kocaefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu U\u00e7kan","family":"\u00c7etinkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"issue":"9","key":"1316_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","volume":"9","author":"C Sobacchi","year":"2013","unstructured":"Sobacchi C, et al. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol. 2013;9(9):522\u201336.","journal-title":"Nat Rev Endocrinol"},{"key":"1316_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-4-5","volume":"4","author":"Z Stark","year":"2009","unstructured":"Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4:5.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1316_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","volume":"42","author":"A Del Fattore","year":"2008","unstructured":"Del Fattore A, Cappariello A, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone. 2008;42(1):19\u201329.","journal-title":"Bone"},{"issue":"3","key":"1316_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i3.20","volume":"20","author":"B Perdu","year":"2010","unstructured":"Perdu B, Van Hul W. Sclerosing bone disorders: too much of a good thing. Crit Rev Eukaryot Gene Expr. 2010;20(3):195\u2013212.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"1316_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","volume":"84","author":"A Villa","year":"2009","unstructured":"Villa A, et al. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int. 2009;84(1):1\u201312.","journal-title":"Calcif Tissue Int"},{"key":"1316_CR6","doi-asserted-by":"publisher","first-page":"7402","DOI":"10.1038\/srep07402","volume":"4","author":"G Pettinato","year":"2014","unstructured":"Pettinato G, Wen X, Zhang N. Formation of well-defined embryoid bodies from dissociated human induced pluripotent stem cells using microfabricated cell-repellent microwell arrays. Sci Rep. 2014;4:7402.","journal-title":"Sci Rep"},{"key":"1316_CR7","doi-asserted-by":"crossref","unstructured":"Choi IY, Lim H, Lee G. Efficient generation human induced pluripotent stem cells from human somatic cells with Sendai-virus. J Vis Exp. 2014;(86):1\u20139.","DOI":"10.3791\/51406"},{"issue":"1","key":"1316_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12272-013-0287-z","volume":"37","author":"HJ Park","year":"2014","unstructured":"Park HJ, et al. Nonviral delivery for reprogramming to pluripotency and differentiation. Arch Pharm Res. 2014;37(1):107\u201319.","journal-title":"Arch Pharm Res"},{"issue":"7151","key":"1316_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313\u20137.","journal-title":"Nature"},{"issue":"4","key":"1316_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrg2937","volume":"12","author":"F Gonzalez","year":"2011","unstructured":"Gonzalez F, Boue S, Izpisua Belmonte JC. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet. 2011;12(4):231\u201342.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"1316_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8(5):409\u201312.","journal-title":"Nat Methods"},{"issue":"5","key":"1316_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618\u201330.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1316_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.stem.2011.05.001","volume":"8","author":"N Miyoshi","year":"2011","unstructured":"Miyoshi N, et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell. 2011;8(6):633\u20138.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"1316_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","volume":"4","author":"H Zhou","year":"2009","unstructured":"Zhou H, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4(5):381\u20134.","journal-title":"Cell Stem Cell"},{"issue":"5928","key":"1316_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"J Yu","year":"2009","unstructured":"Yu J, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324(5928):797\u2013801.","journal-title":"Science"},{"issue":"11","key":"1316_CR16","doi-asserted-by":"publisher","first-page":"e81622","DOI":"10.1371\/journal.pone.0081622","volume":"8","author":"PA Goh","year":"2013","unstructured":"Goh PA, et al. A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS One. 2013;8(11):e81622.","journal-title":"PLoS One"},{"issue":"3","key":"1316_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/stem.1293","volume":"31","author":"K Okita","year":"2013","unstructured":"Okita K, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2013;31(3):458\u201366.","journal-title":"Stem Cells"},{"issue":"14","key":"1316_CR18","doi-asserted-by":"publisher","first-page":"6564","DOI":"10.1128\/JVI.74.14.6564-6569.2000","volume":"74","author":"HO Li","year":"2000","unstructured":"Li HO, et al. A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol. 2000;74(14):6564\u20139.","journal-title":"J Virol"},{"issue":"6","key":"1316_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/cell.2014.0050","volume":"16","author":"I Varela","year":"2014","unstructured":"Varela I, et al. Generation of human beta-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA. Cell Reprogram. 2014;16(6):447\u201355.","journal-title":"Cell Reprogram"},{"issue":"4","key":"1316_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/term.428","volume":"6","author":"H Ohnishi","year":"2012","unstructured":"Ohnishi H, et al. A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2012;6(4):261\u201371.","journal-title":"J Tissue Eng Regen Med"},{"issue":"1","key":"1316_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nbt.3070","volume":"33","author":"TM Schlaeger","year":"2015","unstructured":"Schlaeger TM, et al. A comparison of non-integrating reprogramming methods. Nat Biotechnol. 2015;33(1):58\u201363.","journal-title":"Nat Biotechnol"},{"key":"1316_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-015-0112-3","volume":"6","author":"AM Drozd","year":"2015","unstructured":"Drozd AM, et al. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP\/EBNA-1 episomal reprogramming system. Stem Cell Res Ther. 2015;6:122.","journal-title":"Stem Cell Res Ther"},{"key":"1316_CR23","doi-asserted-by":"crossref","unstructured":"Hartung, O., et al., Clump passaging and expansion of human embryonic and induced pluripotent stem cells on mouse embryonic fibroblast feeder cells. Curr Protoc Stem Cell Biol, 2010. Chapter 1: p. Unit 1C 10.","DOI":"10.1002\/9780470151808.sc01c10s14"},{"issue":"7","key":"1316_CR24","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.","journal-title":"Genome Biol"},{"issue":"3","key":"1316_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrm.2016.8","volume":"17","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Yamanaka S. A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol. 2016;17(3):183\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1316_CR26","first-page":"91","volume":"7","author":"T Foroutan","year":"2016","unstructured":"Foroutan T. Comparison of differentiation of induced pluripotent stem cells and bone-marrow mesenchymal stem cells to osteoblast: osteogenesis versus pluripotency. Int J Organ Transplant Med. 2016;7(2):91\u20136.","journal-title":"Int J Organ Transplant Med"},{"issue":"1","key":"1316_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ijms18010206","volume":"18","author":"Marta Trevisan","year":"2017","unstructured":"Trevisan M, et al. Reprogramming methods do not affect gene expression profile of human induced pluripotent stem cells. Int J Mol Sci. 2017;18(1):206.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"1316_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1566523211313020002","volume":"13","author":"E Bayart","year":"2013","unstructured":"Bayart E, Cohen-Haguenauer O. Technological overview of iPS induction from human adult somatic cells. Curr Gene Ther. 2013;13(2):73\u201392.","journal-title":"Curr Gene Ther"},{"key":"1316_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scr.2018.06.003","volume":"31","author":"HY Choi","year":"2018","unstructured":"Choi HY, et al. Generation of a human induced pluripotent stem cell line, KSCBi003-A, from human adipose tissue-derived mesenchymal stem cells using a chromosomal integration-free system. Stem Cell Res. 2018;31:1\u20134.","journal-title":"Stem Cell Res"},{"issue":"4","key":"1316_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5966\/sctm.2014-0214","volume":"4","author":"BK Chou","year":"2015","unstructured":"Chou BK, et al. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach. Stem Cells Transl Med. 2015;4(4):320\u201332.","journal-title":"Stem Cells Transl Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1316-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T23:23:02Z","timestamp":1594855382000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1316-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1316-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,17]]},"assertion":[{"value":"6 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research was in compliance with the Helsinki Declaration and approved by the Ethics Committee of Hacettepe University. Written informed consents for collection, storage, and use of cells for research purposes were obtained and the study is approved by the Instituonal Review Board of Hacettepe University (Study approval number: 16969557-1213).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}